1	Challenges	challenge	NNS	NNS	_	0	ROOT	_	_
2	in	in	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	control	control	NN	NN	_	2	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	gonorrhea	gonorrhea	NN	NN	_	5	pobj	_	_
7	in	in	IN	IN	_	4	prep	_	_
8	South	South	NNP	NNP	_	9	nn	_	_
9	America	America	NNP	NNP	_	7	pobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	the	the	DT	DT	_	12	det	_	_
12	Caribbean	Caribbean	NNP	NNP	_	9	conj	_	_
13	:	:	:	:	_	1	punct	_	_
14	monitoring	monitor	VBG	VBG	_	1	dep	_	_
15	the	the	DT	DT	_	16	det	_	_
16	development	development	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	resistance	resistance	NN	NN	_	17	pobj	_	_
19	to	to	TO	TO	_	18	prep	_	_
20	antibiotics	antibiotic	NNS	NNS	_	19	pobj	_	_
21	.	.	.	.	_	1	punct	_	_

1	:	:	:	:	_	7	punct	_	_
2	The	the	DT	DT	_	3	det	_	_
3	objective	objective	NN	NN	_	7	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	this	this	DT	DT	_	6	det	_	_
6	study	study	NN	NN	_	4	pobj	_	_
7	was	be	VBD	VBD	_	0	ROOT	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	ascertain	ascertain	VB	VB	_	7	xcomp	_	_
10	the	the	DT	DT	_	12	det	_	_
11	antimicrobial	antimicrobial	JJ	JJ	_	12	amod	_	_
12	susceptibility	susceptibility	NN	NN	_	9	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	Neisseria	Neisseria	NNP	NNP	_	16	nn	_	_
15	gonorrhoeae	gonorrhoeae	NN	NN	_	16	nn	_	_
16	isolates	isolate	NNS	NNS	_	13	pobj	_	_
17	from	from	IN	IN	_	12	prep	_	_
18	6	6	CD	CD	_	20	num	_	_
19	South	South	NNP	NNP	_	20	nn	_	_
20	American	American	NNP	NNP	_	17	pobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	13	13	CD	CD	_	24	num	_	_
23	Caribbean	caribbean	JJ	JJ	_	24	amod	_	_
24	countries	country	NNS	NNS	_	20	conj	_	_
25	participating	participate	VBG	VBG	_	12	vmod	_	_
26	in	in	IN	IN	_	25	prep	_	_
27	the	the	DT	DT	_	31	det	_	_
28	Gonococcal	Gonococcal	NNP	NNP	_	31	nn	_	_
29	Antimicrobial	Antimicrobial	NNP	NNP	_	31	nn	_	_
30	Surveillance	Surveillance	NNP	NNP	_	31	nn	_	_
31	Program	Program	NNP	NNP	_	26	pobj	_	_
32	-LRB-	-lrb-	-LRB-	-LRB-	_	33	punct	_	_
33	GASP	GASP	NNP	NNP	_	31	appos	_	_
34	-RRB-	-rrb-	-RRB-	-RRB-	_	33	punct	_	_
35	from	from	IN	IN	_	25	prep	_	_
36	1990	1990	CD	CD	_	35	pobj	_	_
37	to	to	TO	TO	_	35	prep	_	_
38	1999	1999	CD	CD	_	37	pobj	_	_
39	.	.	.	.	_	7	punct	_	_

1	:	:	:	:	_	8	punct	_	_
2	A	a	DT	DT	_	4	det	_	_
3	GASP	gasp	NN	NN	_	4	nn	_	_
4	network	network	NN	NN	_	8	nsubjpass	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	laboratories	laboratory	NNS	NNS	_	5	pobj	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	launched	launch	VBN	VBN	_	0	ROOT	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	Americas	Americas	NNPS	NNPS	_	9	pobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	the	the	DT	DT	_	14	det	_	_
14	Caribbean	Caribbean	NNP	NNP	_	11	conj	_	_
15	during	during	IN	IN	_	8	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	1990s	1990s	CD	CD	_	15	pobj	_	_
18	.	.	.	.	_	8	punct	_	_

1	Standardized	standardized	JJ	JJ	_	2	amod	_	_
2	methods	method	NNS	NNS	_	7	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	interpretative	interpretative	JJ	JJ	_	5	amod	_	_
5	criteria	criterion	NNS	NNS	_	2	conj	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	established	establish	VBN	VBN	_	0	ROOT	_	_
8	for	for	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	isolation	isolation	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	N.	N.	NNP	NNP	_	13	nn	_	_
13	gonorrhoeae	gonorrhoea	NNS	NNS	_	11	pobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	strain	strain	NN	NN	_	16	nn	_	_
16	identification	identification	NN	NN	_	13	conj	_	_
17	,	,	,	,	_	13	punct	_	_
18	and	and	CC	CC	_	13	cc	_	_
19	determination	determination	NN	NN	_	13	conj	_	_
20	,	,	,	,	_	7	punct	_	_
21	and	and	CC	CC	_	7	cc	_	_
22	quality	quality	NN	NN	_	23	nn	_	_
23	control	control	NN	NN	_	7	conj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	antimicrobial	antimicrobial	JJ	JJ	_	26	amod	_	_
26	susceptibility	susceptibility	NN	NN	_	24	pobj	_	_
27	.	.	.	.	_	7	punct	_	_

1	:	:	:	:	_	9	punct	_	_
2	Two	two	CD	CD	_	3	num	_	_
3	countries	country	NNS	NNS	_	9	nsubj	_	_
4	-LRB-	-lrb-	-LRB-	-LRB-	_	5	punct	_	_
5	Argentina	Argentina	NNP	NNP	_	3	appos	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	Uruguay	Uruguay	NNP	NNP	_	5	conj	_	_
8	-RRB-	-rrb-	-RRB-	-RRB-	_	5	punct	_	_
9	maintained	maintain	VBD	VBD	_	0	ROOT	_	_
10	continuous	continuous	JJ	JJ	_	11	amod	_	_
11	surveillance	surveillance	NN	NN	_	9	dobj	_	_
12	during	during	IN	IN	_	9	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	study	study	NN	NN	_	15	nn	_	_
15	period	period	NN	NN	_	12	pobj	_	_
16	.	.	.	.	_	9	punct	_	_

1	Some	some	DT	DT	_	2	det	_	_
2	countries	country	NNS	NNS	_	3	nsubj	_	_
3	gathered	gather	VBD	VBD	_	0	ROOT	_	_
4	data	datum	NNS	NNS	_	3	dobj	_	_
5	periodically	periodically	RB	RB	_	3	advmod	_	_
6	and	and	CC	CC	_	3	cc	_	_
7	several	several	JJ	JJ	_	8	amod	_	_
8	others	other	NNS	NNS	_	10	nsubj	_	_
9	were	be	VBD	VBD	_	10	cop	_	_
10	unable	unable	JJ	JJ	_	3	conj	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	initiate	initiate	VB	VB	_	10	xcomp	_	_
13	antimicrobial	antimicrobial	JJ	JJ	_	14	amod	_	_
14	surveillance	surveillance	NN	NN	_	12	dobj	_	_
15	as	as	IN	IN	_	12	prep	_	_
16	a	a	DT	DT	_	17	det	_	_
17	result	result	NN	NN	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	lack	lack	NN	NN	_	18	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	resources	resource	NNS	NNS	_	20	pobj	_	_
22	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	percentage	percentage	NN	NN	_	14	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	penicillin-resistant	penicillin-resistant	JJ	JJ	_	6	amod	_	_
5	N.	N.	NNP	NNP	_	6	nn	_	_
6	gonorrhoeae	gonorrhoea	NNS	NNS	_	3	pobj	_	_
7	isolated	isolate	VBN	VBN	_	6	vmod	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	region	region	NN	NN	_	8	pobj	_	_
11	over	over	IN	IN	_	2	prep	_	_
12	the	the	DT	DT	_	13	det	_	_
13	decade	decade	NN	NN	_	11	pobj	_	_
14	varied	vary	VBD	VBD	_	0	ROOT	_	_
15	considerably	considerably	RB	RB	_	14	advmod	_	_
16	-LRB-	-lrb-	-LRB-	-LRB-	_	19	punct	_	_
17	1.0-11.9	1.0-11.9	CD	CD	_	18	num	_	_
18	%	%	NN	NN	_	19	nsubj	_	_
19	carried	carry	VBD	VBD	_	14	dep	_	_
20	chromosomal	chromosomal	JJ	JJ	_	21	amod	_	_
21	resistance	resistance	NN	NN	_	25	nsubj	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	17.9-38.8	17.9-38.8	CD	CD	_	24	num	_	_
24	%	%	NN	NN	_	21	conj	_	_
25	produced	produce	VBD	VBD	_	19	ccomp	_	_
26	beta-lactamase	beta-lactamase	NN	NN	_	25	dobj	_	_
27	-RRB-	-rrb-	-RRB-	-RRB-	_	19	punct	_	_
28	with	with	IN	IN	_	19	prep	_	_
29	an	a	DT	DT	_	31	det	_	_
30	overall	overall	JJ	JJ	_	31	amod	_	_
31	trend	trend	NN	NN	_	28	pobj	_	_
32	to	to	TO	TO	_	31	prep	_	_
33	declining	decline	VBG	VBG	_	34	amod	_	_
34	numbers	number	NNS	NNS	_	32	pobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	penicillin-resistant	penicillin-resistant	JJ	JJ	_	37	amod	_	_
37	isolates	isolate	NNS	NNS	_	35	pobj	_	_
38	.	.	.	.	_	14	punct	_	_

1	For	for	IN	IN	_	9	prep	_	_
2	tetracycline	tetracycline	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	9	punct	_	_
4	7.4	7.4	CD	CD	_	9	dep	_	_
5	%	%	NN	NN	_	9	nsubj	_	_
6	to	to	TO	TO	_	5	prep	_	_
7	36.3	36.3	CD	CD	_	8	num	_	_
8	%	%	NN	NN	_	6	pobj	_	_
9	carried	carry	VBD	VBD	_	0	ROOT	_	_
10	chromosomal	chromosomal	JJ	JJ	_	11	amod	_	_
11	resistance	resistance	NN	NN	_	9	dobj	_	_
12	,	,	,	,	_	9	punct	_	_
13	whereas	whereas	IN	IN	_	9	dep	_	_
14	12.0	12.0	CD	CD	_	15	num	_	_
15	%	%	NN	NN	_	19	nsubj	_	_
16	to	to	TO	TO	_	15	prep	_	_
17	27.4	27.4	CD	CD	_	18	num	_	_
18	%	%	NN	NN	_	16	pobj	_	_
19	carried	carry	VBD	VBD	_	9	parataxis	_	_
20	plasmid-mediated	plasmid-mediated	JJ	JJ	_	21	amod	_	_
21	resistance	resistance	NN	NN	_	19	dobj	_	_
22	.	.	.	.	_	9	punct	_	_

1	There	there	EX	EX	_	2	expl	_	_
2	were	be	VBD	VBD	_	0	ROOT	_	_
3	no	no	DT	DT	_	4	neg	_	_
4	reports	report	NNS	NNS	_	2	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	ciprofloxacin-resistant	ciprofloxacin-resistant	JJ	JJ	_	7	amod	_	_
7	isolates	isolate	NNS	NNS	_	5	pobj	_	_
8	,	,	,	,	_	2	punct	_	_
9	although	although	IN	IN	_	25	mark	_	_
10	N.	N.	NNP	NNP	_	11	nn	_	_
11	gonorrhoeae	gonorrhoea	NNS	NNS	_	25	nsubjpass	_	_
12	with	with	IN	IN	_	11	prep	_	_
13	decreased	decrease	VBN	VBN	_	14	amod	_	_
14	susceptibility	susceptibility	NN	NN	_	12	pobj	_	_
15	to	to	TO	TO	_	14	prep	_	_
16	ciprofloxacin	ciprofloxacin	NN	NN	_	15	pobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	azithromycin	azithromycin	NN	NN	_	16	conj	_	_
19	as	as	RB	RB	_	20	advmod	_	_
20	well	well	RB	RB	_	14	cc	_	_
21	as	as	IN	IN	_	20	mwe	_	_
22	spectinomycin-resistant	spectinomycin-resistant	JJ	JJ	_	23	amod	_	_
23	isolates	isolate	NNS	NNS	_	14	conj	_	_
24	were	be	VBD	VBD	_	25	auxpass	_	_
25	identified	identify	VBN	VBN	_	2	advcl	_	_
26	in	in	IN	IN	_	25	prep	_	_
27	some	some	DT	DT	_	28	det	_	_
28	countries	country	NNS	NNS	_	26	pobj	_	_
29	.	.	.	.	_	2	punct	_	_
